Novel amyloid beta oligomer specific binding molecule
WO2010059046A1
Cross-beta structures as carriers in vaccines
EP2058000A1
Immunogenic compositions capable of activating T cells
EP2058001A1
Enhancement of immunogenicity of antigens
CA2645930A1
Methods of binding of cross-beta structures by chaperones
AU2006267174A1
Adjuvation through cross-beta structure
AU2006267177A1
Methods for determining the effect of a treatment on the cross-beta structure content of a protein; selection of treatments and uses thereof
AU2006267173A1
A method for detecting peptides comprising a cross-B structure
AU2006267176A1
Cross-beta structure binding compounds
EP1864140A2
Method for interferingwith blood coagulation by modulating cross-beta structures fibril formation
US2009202980A1
Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With Blood Coagulation
